Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Prenatal testing breakthrough

For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.

Norwegian describes scrapie gene

Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.

Fat cells' reaction differs with body weight

The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...

”Ny antibiotika kräver ny modell”

”Vi vill att det ska finnas antibiotika för alla infektioner, men samtidigt vill vi att de används så lite som möjligt”, säger John H Rex vid Astrazenecas affär...

Vart tog ljuset i tunneln vägen?

Det är mycket svårt att utveckla läkemedel mot de stora volymsjukdomarna

EU says yes to Roche drug

EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.

Synkrotronljus viktigt för life science

- Utvecklingen är ändå bara i sin början. Nya synkrotronljusanläggningar poppar upp som svampar i Europa, säger Olof Hallonsten som nyligen har disputerat i ämnet.

Showroom for free

The latest equipment with trained staff. Sci Life Lab in Stockholm want to offer top conditions at the new imaging laboratory. But some vendors are skeptical to...

Mingling types - who to aim for and who to avoid:

Read about different mingling types - who are you?

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Lundaforskare får Akzonobels pris

Två forskare belönas med 500 000 kronor för sin forskning och entreprenörsanda.

Re-painting the big pig-ture

Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Bio engineering breakthrough in Denmark

Brand new research makes BioGasol's cellulosic ethanol process even more competitive.

Hårdare krav på godkännanden i EU än i USA?

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.

LEO Pharma - International Clinical Trial Manager

How to be a perfect mingler

Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, ...

New map of eye proteins

A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.

Time to save for survival

The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.

Hallå där Sara Melén...

... som forskar och föreläser om små internationella företag. Biotech-branschen erbjuder typexempel på bolag som lyckas och ser den internationella marknaden so...

Innovation på agendan

Hur attraktivt är Sverige för innovativa människor och företag? Det var temat för innovationsmyndigheten Vinnovas årskonferens som hölls i dag tisdag på Stockholm Waterfront.

Småbolagen vinnare vid uppköp

De mindre biotech-bolagen är de stora vinnarna när patentklyftan närmar sig. Ny forskning visar att Big Pharma pungar ut med betydligt högre budpremier än bolag...